Neurocognitive deficits and disability in major depressive disorder

被引:395
|
作者
Jaeger, Judith
Berns, Stefanie
Uzelac, Sarah
Davis-Conway, Sara
机构
[1] Long Isl Jewish Med Ctr, Hillside Hosp, Ctr Neuropsychiat Outcome & Rehabil Res, Glen Oaks, NY 11004 USA
[2] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA
[3] Mt St Marys Coll, Dept Psychol, Newburgh, NY USA
关键词
major depressive disorder; neurocognitive deficits; disability; cognitive function; neuropsychological tests; functional recovery;
D O I
10.1016/j.psychres.2005.11.011
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Disability in life functioning is an important and poorly understood consequence of major depressive disorder (MDD). Mood symptoms do not account for the magnitude of disability resulting from MDD. Impairments in several domains of neurocognitive (NC) functioning have been shown to interfere with functionality in other psychiatric populations. These deficits, also present in MDD, may play a significant role in disability experienced by many with this disorder. The aim of this study was to examine the degree to which NC deficits, independent of affective and psychotic symptoms, explain functional outcome 6 months following hospitalization for a major depressive episode. Participants with an MDD diagnosis (N = 48) received NC testing and symptom ratings while in the hospital. These procedures were repeated, along with functionality ratings, 6 months later. Six-month NC performance was strongly associated with functionality ratings after covariation for residual depression. Selected NC domains tested at baseline were predictive of functionality at 6 months. These data indicate that NC deficits, at least for some MDD sufferers, play an important role in functional recovery. New treatments, whether pharmacologic or rehabilitative, may be required to help affected patients accommodate neurocognitively based performance deficits at work, at home and in the community. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 50 条
  • [1] Neurocognitive Subgroups in Major Depressive Disorder
    Martin, Donel M.
    Wollny-Huttarsch, David
    Nikolin, Stevan
    McClintock, Shawn M.
    Alonzo, Angelo
    Lisanby, Sarah H.
    Loo, Colleen K.
    [J]. NEUROPSYCHOLOGY, 2020, 34 (06) : 726 - 734
  • [2] Neurocognitive Impairment in Major Depressive Disorder
    Silva Ribeiro, J.
    Pestana Santos, A.
    Rosa, L.
    Amilcar, J.
    [J]. EUROPEAN PSYCHIATRY, 2015, 30
  • [3] Neurocognitive Dysfunction in Patients of Major Depressive Disorder
    Shah, Bhavik
    Kataria, Lakhan
    Tanna, Kajal
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2016, 58 (05) : S44 - S44
  • [4] Recurrence in major depressive disorder: a neurocognitive perspective
    Robinson, O. J.
    Sahakian, B. J.
    [J]. PSYCHOLOGICAL MEDICINE, 2008, 38 (03) : 315 - 318
  • [5] Hedonic Deficits in Schizophrenia and Major Depressive Disorder
    Saperia, Sarah
    Da Silva, Susana
    Siddiqui, Ishraq
    Agid, Ofer
    Daskalakis, Jeff
    Ravindran, Arun
    Voineskos, Aristotle
    Zakzanis, Konstantine
    Remington, Gary
    Foussias, George
    [J]. BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S420 - S420
  • [6] Cognitive Deficits in Adolescents with Major Depressive Disorder
    Pearlson, J.
    Scarisbrick, D.
    Rodriguez, M.
    Golden, C.
    [J]. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2010, 25 (06) : 514 - 514
  • [7] Microstructural deficits of the thalamus in major depressive disorder
    Zhang, Yuxuan
    Zhang, Yingli
    Ai, Hui
    Van Dam, Nicholas T.
    Qian, Long
    Hou, Gangqiang
    Xu, Pengfei
    [J]. BRAIN COMMUNICATIONS, 2022, 4 (05)
  • [8] The treatment of cognitive deficits in major depressive disorder
    Baldwin, David S.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2013, 17 : 4 - 4
  • [9] Evidence for GABA Deficits in Major Depressive Disorder
    Levinson, Andrea J.
    [J]. BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 211S - 211S
  • [10] Anhedonia in major depressive disorder: the role of neurocognitive profiles
    Biso, L.
    Cimatti, M.
    Carnevali, F.
    Camerlengo, A.
    Ossola, P.
    Marchesi, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S235 - S236